Lilly Diabetes Scholarship Program
As part of its ongoing commitment to patients with diabetes, Eli Lilly and Company will once again offer the Lilly For Learning Diabetes Scholarship Program, a national scholarship program designed to assist students with Type 1 diabetes who will be attending an accredited public or private institution of higher learning.
Lilly will award fifty $2,500 scholarships to be applied toward the recipient's college tuition for the 1999-2000 academic year. To be eligible for a Lilly For Learning Diabetes Scholarship, students must meet the following criteria:
- have been diagnosed with Type 1 diabetes
- will attend an accredited public or private school in the United States as a full-time undergraduate student
- show significant involvement in the diabetes community
- have contributed to the promotion of diabetes awareness or overcome specific obstacles with respect to living with diabetes.
Selection criteria will be based on academic achievement, Scholastic Aptitude Test (SAT) or Academic Achievement Test (ACT) scores, diabetes-related activities, extracurricular activities, a written essay, and both a personal recommendation and a medical recommendation by a physician or diabetes educator.
Final selection of scholarship recipients will be made by the Lilly For Learning Diabetes Scholarship Advisory Panel, an independent board of diabetes physicians and educators from across the United States.
To obtain a scholarship application packet, students may call 1-888-88-LILLY or visit Eli Lilly and Company's diabetes website.
Last Updated: Sunday December 05, 2004 11:17:24
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.